401 related articles for article (PubMed ID: 27750047)
21. Activation of non-myogenic mesenchymal stem cells during the disease progression in dystrophic dystrophin/utrophin knockout mice.
Sohn J; Lu A; Tang Y; Wang B; Huard J
Hum Mol Genet; 2015 Jul; 24(13):3814-29. PubMed ID: 25859011
[TBL] [Abstract][Full Text] [Related]
22. Celecoxib treatment improves muscle function in mdx mice and increases utrophin A expression.
Péladeau C; Adam NJ; Jasmin BJ
FASEB J; 2018 Sep; 32(9):5090-5103. PubMed ID: 29723037
[TBL] [Abstract][Full Text] [Related]
23. Lipin1 plays complementary roles in myofibre stability and regeneration in dystrophic muscles.
Jama A; Alshudukhi AA; Burke S; Dong L; Kamau JK; Voss AA; Ren H
J Physiol; 2023 Mar; 601(5):961-978. PubMed ID: 36715084
[TBL] [Abstract][Full Text] [Related]
24. Glycine administration attenuates progression of dystrophic pathology in prednisolone-treated dystrophin/utrophin null mice.
Ham DJ; Gardner A; Kennedy TL; Trieu J; Naim T; Chee A; Alves FM; Caldow MK; Lynch GS; Koopman R
Sci Rep; 2019 Sep; 9(1):12982. PubMed ID: 31506484
[TBL] [Abstract][Full Text] [Related]
25. Restoration of all dystrophin protein interactions by functional domains in trans does not rescue dystrophy.
Gardner KL; Kearney JA; Edwards JD; Rafael-Fortney JA
Gene Ther; 2006 May; 13(9):744-51. PubMed ID: 16307000
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic potential of PEGylated insulin-like growth factor I for skeletal muscle disease evaluated in two murine models of muscular dystrophy.
Gehrig SM; van der Poel C; Hoeflich A; Naim T; Lynch GS; Metzger F
Growth Horm IGF Res; 2012 Apr; 22(2):69-75. PubMed ID: 22424862
[TBL] [Abstract][Full Text] [Related]
27. Social stress is lethal in the mdx model of Duchenne muscular dystrophy.
Razzoli M; Lindsay A; Law ML; Chamberlain CM; Southern WM; Berg M; Osborn J; Engeland WC; Metzger JM; Ervasti JM; Bartolomucci A
EBioMedicine; 2020 May; 55():102700. PubMed ID: 32192914
[TBL] [Abstract][Full Text] [Related]
28. Embryonic myosin is a regeneration marker to monitor utrophin-based therapies for DMD.
Guiraud S; Edwards B; Squire SE; Moir L; Berg A; Babbs A; Ramadan N; Wood MJ; Davies KE
Hum Mol Genet; 2019 Jan; 28(2):307-319. PubMed ID: 30304405
[TBL] [Abstract][Full Text] [Related]
29. Utrophin A is essential in mediating the functional adaptations of mdx mouse muscle following chronic AMPK activation.
Al-Rewashdy H; Ljubicic V; Lin W; Renaud JM; Jasmin BJ
Hum Mol Genet; 2015 Mar; 24(5):1243-55. PubMed ID: 25324540
[TBL] [Abstract][Full Text] [Related]
30. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.
Burkin DJ; Wallace GQ; Nicol KJ; Kaufman DJ; Kaufman SJ
J Cell Biol; 2001 Mar; 152(6):1207-18. PubMed ID: 11257121
[TBL] [Abstract][Full Text] [Related]
31. Utrophin deficiency worsens cardiac contractile dysfunction present in dystrophin-deficient mdx mice.
Janssen PM; Hiranandani N; Mays TA; Rafael-Fortney JA
Am J Physiol Heart Circ Physiol; 2005 Dec; 289(6):H2373-8. PubMed ID: 16024571
[TBL] [Abstract][Full Text] [Related]
32. Loss of sarcospan exacerbates pathology in mdx mice, but does not affect utrophin amelioration of disease.
Gibbs EM; McCourt JL; Shin KM; Hammond KG; Marshall JL; Crosbie RH
Hum Mol Genet; 2021 Apr; 30(3-4):149-159. PubMed ID: 33432327
[TBL] [Abstract][Full Text] [Related]
33. Dystrophic mdx mice develop severe cardiac and respiratory dysfunction following genetic ablation of the anti-inflammatory cytokine IL-10.
Nitahara-Kasahara Y; Hayashita-Kinoh H; Chiyo T; Nishiyama A; Okada H; Takeda S; Okada T
Hum Mol Genet; 2014 Aug; 23(15):3990-4000. PubMed ID: 24659498
[TBL] [Abstract][Full Text] [Related]
34. [Study on the gene knockout model mice of Duchenne muscular dystrophy].
Chen S; Zhang C; Liu X; Gao L; Zhang W; Huang W; Lu X; Wang Z
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Apr; 34(2):210-3. PubMed ID: 12947691
[TBL] [Abstract][Full Text] [Related]
35. SERCA1 overexpression minimizes skeletal muscle damage in dystrophic mouse models.
Mázala DA; Pratt SJP; Chen D; Molkentin JD; Lovering RM; Chin ER
Am J Physiol Cell Physiol; 2015 May; 308(9):C699-709. PubMed ID: 25652448
[TBL] [Abstract][Full Text] [Related]
36. Long-term quercetin dietary enrichment decreases muscle injury in mdx mice.
Hollinger K; Shanely RA; Quindry JC; Selsby JT
Clin Nutr; 2015 Jun; 34(3):515-22. PubMed ID: 24998094
[TBL] [Abstract][Full Text] [Related]
37. Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice.
Ebihara S; Guibinga GH; Gilbert R; Nalbantoglu J; Massie B; Karpati G; Petrof BJ
Physiol Genomics; 2000 Sep; 3(3):133-44. PubMed ID: 11015608
[TBL] [Abstract][Full Text] [Related]
38. RhoA/ROCK inhibition improves the beneficial effects of glucocorticoid treatment in dystrophic muscle: implications for stem cell depletion.
Mu X; Tang Y; Takayama K; Chen W; Lu A; Wang B; Weiss K; Huard J
Hum Mol Genet; 2017 Aug; 26(15):2813-2824. PubMed ID: 28549178
[TBL] [Abstract][Full Text] [Related]
39. Desmin prevents muscle wasting, exaggerated weakness and fragility, and fatigue in dystrophic mdx mouse.
Ferry A; Messéant J; Parlakian A; Lemaitre M; Roy P; Delacroix C; Lilienbaum A; Hovhannisyan Y; Furling D; Klein A; Li Z; Agbulut O
J Physiol; 2020 Sep; 598(17):3667-3689. PubMed ID: 32515007
[TBL] [Abstract][Full Text] [Related]
40. Low dystrophin levels increase survival and improve muscle pathology and function in dystrophin/utrophin double-knockout mice.
van Putten M; Hulsker M; Young C; Nadarajah VD; Heemskerk H; van der Weerd L; 't Hoen PA; van Ommen GJ; Aartsma-Rus AM
FASEB J; 2013 Jun; 27(6):2484-95. PubMed ID: 23460734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]